首页> 外国专利> composition, methods for inhibiting vascular permeability, pathological angiogenesis, and one plus rac activation or availability, arf6 activation or availability, vascular leakage, vascular permeability, pathological angiogenesis, and signal inhibition of multiple angiogenic, permeability, and inflammatory factors, and methods for preserving endothelial barrier function, and for blocking vegf signaling downstream of the vegf receptor

composition, methods for inhibiting vascular permeability, pathological angiogenesis, and one plus rac activation or availability, arf6 activation or availability, vascular leakage, vascular permeability, pathological angiogenesis, and signal inhibition of multiple angiogenic, permeability, and inflammatory factors, and methods for preserving endothelial barrier function, and for blocking vegf signaling downstream of the vegf receptor

机译:组成,抑制血管通透性,病理性血管生成的方法,以及一个或多个rac激活或可用性,arf6激活或可用性,血管渗漏,血管通透性,病理性血管生成以及多种血管生成,通透性和炎性因子的信号抑制以及保存方法内皮屏障功能,用于阻断vegf受体下游的vegf信号传导

摘要

Compounds, compositions and methods for inhibiting vascular permeability and pathologic angiogenesis by modulating a signaling pathway delineated herein are described. Moreover, methods for producing and screening compounds and compositions capable of modulating the signaling pathway described herein, inhibiting vascular permeability, and inhibiting pathologic angiogenesis are also provided.
机译:描述了通过调节本文所述的信号传导途径来抑制血管通透性和病理性血管生成的化合物,组合物和方法。此外,还提供了产生和筛选能够调节本文所述的信号传导途径,抑制血管渗透性和抑制病理性血管生成的化合物和组合物的方法。

著录项

  • 公开/公告号BRPI0903901A2

    专利类型

  • 公开/公告日2017-05-23

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF UTAH RESEARCH FOUDATION;

    申请/专利号BR2009PI03901

  • 发明设计人 CHRISTOPHER JONES;DEAN LI;NYALL LONDON;

    申请日2009-04-16

  • 分类号A61K38/16;A61K31/4196;A61P9/10;A61P11;A61P19/02;A61P27/02;A61P29;A61P35;

  • 国家 BR

  • 入库时间 2022-08-21 13:39:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号